Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients

AIDS

Volumn 12, Issue 2, 1998, Pages 125-129

  Gilbert, Christian ^a   Handfield, Julie ^a   Toma, Emil ^b   Lalonde, Richard ^c   Bergeron, Michel G ^a   Boivin, Guy ^a,d  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

Cytomegalovirus; Ganciclovir; Resistance; Retinitis progression; Viral load

Indexed keywords

GANCICLOVIR; RESTRICTION ENDONUCLEASE; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; RETINITIS; TREATMENT OUTCOME; VIRUS LOAD; VIRUS MUTATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; DISEASE PROGRESSION; DNA, VIRAL; DRUG RESISTANCE, MICROBIAL; GANCICLOVIR; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; NEUTROPHILS; POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 0032556975     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199802000-00001     Document Type: Article

References (15)

1. Drew W: Cytomegalovirus infection in patients with AIDS. Clin Infect Dis 1992, 14:608-615.
2. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group: Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992, 326:213-219.
3. Studies of ocular complications of AIDS research group, AIDS clinical trials group: Foscarnet-ganciclovir cytomegalovirus retinitis trial, 4: visual outcomes. Ophthalmology 1994, 101:1250-1261.
4. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group: Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. Arch Ophthalmol 1996, 114:23-33.
5. Erice A, Gil-Roda C, Perez JL, et al.: Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus strains from immunocompromised patients. J Infect Dis 1997, 175:1087-1092.
6. Boivin G, Chou S, Quirk MR, Erice A, Jordan MC: Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. J Infect Dis 1996, 173:523-528.
7. Chou S, Erice A, Jordan MC, et al.: Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis 1995, 171:576-583.
8. Drew WL, Miner RC, Busch DF, et al.: Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis 1991, 163:716-719.
9. Smith IL, Shinkai M, Freeman WR, Spector SA: Polyradiculopathy associated with ganciclovir-resistant cytomegalovirus in an AIDS patient : phenotypic and genotypic characterization of sequential virus isolates. J Infect Dis 1996, 173:1481-1484.
10. Baldanti F, Silini E, Sarasini A, et al.: A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol 1995, 69:796-800.
11. Chou S, Guentzel S, Michels KR, Miner RC, Drew WL: Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis 1995, 172:239-242.
12. Lurain NS, Thompson KD, Holmes EW, Read GS: Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents. J Virol 1992, 66:7146-7152.
13. Boivin G, Handfield J, Murray G, et al.: Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the SHARP Signal Detection System. J Clin Microbiol 1997, 35:525-526.
14. Jokela J, Erice A, Stanat S, et al.: A standardized plaque reduction assay for CMV antiviral susceptibility. Second Conference on Human Retroviruses and Opportunistic Infections. Washington DC, January 1995 [abstract 283].
15. Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, Pergolizzi R: Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 1996, 174:184-187.